Sunrise, Solid tumor cancer stem cell network

New publication from our members: progastrin is produced within intestinal crypts by a subset of Bmi1+/Prox1+/LGR5 low endocrine cells but LGR5 high cells become the main source of progastrin production in early mouse and human intestinal adenomas. pubmed.ncbi.nlm.nih.gov/33360…

Last week from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

A very interesting story to start the week! Enjoy! twitter.com/LabTurtoi/stat…

Last week from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

RT @CellCellPress Out now! #Cancer cells can enter a quiescent state in response to #chemotherapy and subsequently emerge rejuvenated bit.ly/399klMV @UHN @UHN_Research pic.twitter.com/xAIcxAcQJM

About 2 weeks ago from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

RT @CedricBlanpain We are looking for a talented postdoc to perform translational research between the academy and ChromaCure, a recent spin-off of the ULB that develops small molecule therapeutics in oncology. Inquiries should be sent to labblanp@ulb.ac.be. Please retweet

About 2 weeks ago from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

The SUNRiSE consortium wishes you a Happy New Year with great success and discoveries!

About 3 weeks ago from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

And now, a session about CSC in melanoma given by @CARAMELJulie1 ! Enjoy ! pic.twitter.com/gHf78SCbsW

About a month ago from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

Session about CSC in Colorectal cancer given by J.Pannequin. Next session, given by @DamsGREGOIRE will be about the CSC concept in hepatocarcinoma! pic.twitter.com/md1HeDWl4R

About a month ago from solid tumor cancer stem cell network's Twitter via Twitter for iPhone

NEWSROOM

SUNRiSE Extraordinary General Meeting

Progastrin production transitions during early intestinal tumorigenesis

CD44 regulates epigenetic plasticity by mediating iron endocytosis

Heterotypic cell–cell communication regulates glandular stem cell multipotency

SUNRiSE Webinars

5 February - 15:00 to 17:00

4th SUNRiSE training session « Stem cells in solid tumors: from biology to therapy »

17/12/2020 to 18/12/2020

Theatre performance in favour of SUNRiSE network

28/09/2019 - 08:00 to 17:00

3rd SUNRiSE Meeting “New advances in Cancer Stem Cells”

16/05/2019 - 08:30 to 17/05/2019 - 17:30chateau valrose

ABOUT

Solid Tumor Cancer Stem Cell Network
The « Cancer Stem Cell » Network (SUNRiSE, Solid Tumor Cancer Stem Cell Network) aims at promoting basic and translational research in the field of cancer stem cells in solid tumors…

PUBLICATIONS

Organotypic Modeling of the Tumor Landscape Autophagy in Osteosarcoma Cancer Stem Cells Is Critical Process which Can Be Targeted by the Antipsychotic Drug Thioridazine Progastrin production transitions from Bmi1+/Prox1+ to Lgr5high cells during early intestinal tumorigenesis.Direct and Indirect Regulators of Epithelial-Mesenchymal Transition (EMT)-mediated Immunosuppression in Breast Carcinomas CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies

KEY FIGURES

179

SUNRiSE Members

149

SUNRiSE Trainees

SUNRiSE Meetings

MEETING

Fueling an international community with CSC expertises.
Allowing best international experts to meet and exchange on breakthrough discoveries about cancer stem cells is one of our network priorities. Because together is always better than alone, this unique opportunity in France allows important collaborations to rapidly develop efficient weapons to fight against cancer. The SUNRiSE network organizes, once every 2 years, international meetings in French cities to allow the spread of the most important discoveries in the field of cancer stem cells.

EDUCATION

Training sessions on cancer stem cells (CSC).
Since SUNRiSE Network has been created, our first priority has been to train young researchers and medical doctors to this important topic. We also aim at increasing their awareness to include cancer stem cells in their research to fight against cancer. If we want a change in the paradigm of cancer evolution and cure, education is the mainstay of this revolution. It is also necessary to educate and sensitize people working in pharmaceutical companies as well as clinicians to encourage them to respectively develop treatments to eliminate CSC and to organize clinical trials including these innovative and promising new medicines for patients.

JOIN SUNRISE

Becoming a member of the SUNRiSE Network is being part of an active network made up of students, scientists and clinicians with a common interest for the cancer stem cell field in solid tumors. Membership in the SUNRiSE Network is open to individuals who are interested in cancer stem cell research and cancer-stem cell-based medicine (…)

QUESTION ABOUT SUNRiSE?

LET’S TALK!

QUESTION À PROPOS DE SUNRiSE

CONTACTEZ-NOUS!

Solid tumor cancer stem cell network